Associations of plasma p‐Tau217 with cognitive domain performance in clinically unimpaired participants: Evidence from HABS‐HD
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-04 · 18 (2)
DOI: 10.1002/dad2.70370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, online erschienen am 03.06.2026. Verfasst von Zara Najmi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience University of California Berkley Berkley California USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIBIB NIH HHS, NIA NIH HHS, Burroughs Wellcome Fund.
Abstract (Originalsprache)
INTRODUCTION The relationship between plasma phosphorylated tau 217 (p‐Tau217) and domain‐specific cognitive performance across race and ethnic groups remains unclear. METHODS We analyzed data from 2052 clinically unimpaired participants from the Health & Aging Brain Study–Health Disparities cohort. Using adjusted multivariable linear regressions, we evaluated the associations between p‐Tau217 and cognitive scores (immediate and delayed memory, attention/processing speed, executive function, and language). Analyses were conducted in the overall sample, stratified by race and ethnicity, and in an age‐ and sex‐matched subsample ( n = 1032). RESULTS Plasma p‐Tau217 levels were lower in Non‐Hispanic Black (NHB) and Hispanic participants ( p < 0.001) despite lower cognitive scores ( p < 0.001). Higher p‐Tau217 was associated with worse cognition overall ( β −0.05 to −0.11). Associations were strongest in Non‐Hispanic White (NHW), limited in NHB, and domain‐specific in Hispanic groups. Matched analyses attenuated effects. DISCUSSION Plasma p‐Tau217 is associated with domain‐specific cognitive performance in clinically unimpaired individuals, but these associations vary across racial and ethnic groups.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuroscience University of California Berkley Berkley California USA.
- Department of Psychiatry, Healthy Brain Aging Sleep Center NYU Grossman School of Medicine New York New York USA.
- Department of Neurosciences, Alzheimer's Disease Cooperative Study University of California San Diego San Diego California USA.
- Department of Epidemiology and Population Health Stanford University School of Medicine Palo Alto California USA.
Förderung
- NIBIB NIH HHS
- NIA NIH HHS
- Burroughs Wellcome Fund
Zitieren
APA
Najmi, Z., Dharmapuri, A., Contreras, J. A., Hayes, C. A., & Health and Aging Brain Study (HABS‐HD) Study Team (2026). Associations of plasma p‐Tau217 with cognitive domain performance in clinically unimpaired participants: Evidence from HABS‐HD. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 18(2). https://doi.org/10.1002/dad2.70370
Vancouver
Najmi Z, Dharmapuri A, Contreras JA, Hayes CA, Health and Aging Brain Study (HABS‐HD) Study Team. Associations of plasma p‐Tau217 with cognitive domain performance in clinically unimpaired participants: Evidence from HABS‐HD. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2026;18(2). doi:10.1002/dad2.70370
BibTeX
@article{Najmi2026,
author = {Najmi, Zara and Dharmapuri, Anhiti and Contreras, Joey A and Hayes, Cellas A and Health and Aging Brain Study (HABS‐HD) Study Team, Health and Aging Brain Study (HABS‐HD) Study Team},
title = {Associations of plasma p‐Tau217 with cognitive domain performance in clinically unimpaired participants: Evidence from HABS‐HD},
journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
year = {2026},
volume = {18},
number = {2},
doi = {10.1002/dad2.70370}
}
EUVIMED